- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Eli Lilly and Co.
Teva gets European OK to sell generic of Lilly's Evista
February 19, 2010
Bloomberg NewsEvista generated $1.03 billion in sales last year, of which $348.1 million came outside the United States.
MorePfizer's Viagra patent partially rejected in Lilly fight
February 16, 2010
Bloomberg NewsThe patent on impotence drug Viagra was partially rejected after the U.S. Patent and Trademark Office said it wasn't different
enough from a Chinese herb known as Horny Goat Weed. The patent was key to an infringement suit Pfizer filed in 2002 against
Eli Lilly and Co. over its rival Cialis drug.
MoreLilly awards pay increases to top executives
February 8, 2010
Peter Schnitzler, J.K. WallEli Lilly and Co. CEO John Lechleiter's total compensation increased $4.1 million in 2009.
MoreMississippi settles Zyprexa suit against Lilly for over $18M
February 4, 2010
Associated PressMississippi will receive $18.5 million from Indianapolis-based drugmaker Eli Lilly and Co. as part of a settlement over claims
the company promoted the anti-psychotic Zyprexa for ailments it was not federally approved to treat.
MoreQ&A: Dr. Kristine Courtney
February 3, 2010
J.K. WallDr. Kristine Courtney, Eli Lilly and Co.’s senior director of corporate health services, describes
how and why the company spent two years making its clinics some of the first to electronically swap patient records with
a local hospital database.
MoreLilly shares trade down after fourth-quarter profits falls
January 28, 2010
J.K. WallAnalysts worry about dive in already paltry sales of new blood thinner Effient
MoreLilly's profits fall, miss analyst expectations
January 28, 2010
J.K. WallThe Indianapolis-based drugmaker says a weaker dollar depressed earnings in the fourth quarter compared with a year ago.
MoreLilly looks to autoimmune drugs
January 27, 2010
J.K. WallTwo local researchers show why Eli Lilly and Co. and its peers are interested in developing medicines to treat automimmune
diseases: The costs of treating them are growing twice as fast as the prescription drug market.
MoreLilly shares get boost from OK of rival's drug
January 26, 2010
IBJ Staff and Bloomberg NewsShares of Lilly and partner Amylin rose on hopes that their new version of Byetta will be approved following U.S. regulators'
clearance of a similar drug.
MoreBiotech firm plans $28M Greenwood plant
January 19, 2010
Greenwood pharmaceutical firm Elona Biotechnologies plans to build a $28 million production facility and create 70 jobs to
help develop a cheaper form of insulin that could gain significant market share.
MoreFDA letters scold Lilly, others over marketing materials
January 13, 2010
Associated PressThe letter to Indianapolis-based Lilly cites a print advertisement for the antidepressant Cymbalta that did not adequately
display information about the drug's side effects.
MoreFDA cancels meeting to review Lilly's Cymbalta
January 5, 2010
Associated PressThe agency said the meeting was canceled "to allow time for the FDA to review new information" about a proposed new use for
the drug.
MoreRuth Lilly remembered for 'selfless' giving
December 31, 2009
Andrea Muirragui DavisLilly, 94, who died Wednesday, gave away hundreds of millions of dollars of her fortune during her lifetime.
MoreEli Lilly and Co. heiress Ruth Lilly dies at 94
December 31, 2009
Associated PressOver the course of her life, the last surviving great-grandchild of pharmaceutical magnate Eli Lilly gave away much of her
inheritance.
MoreCorporations bet on insiders to bend reform
December 30, 2009
J.K. WallIndianapolis health care heavyweights are among those spending $635 million, employing 166 former aides to key congressional
leaders and committees in health reform process.
MoreLilly scurries to get out from under Zyprexa cloud
December 26, 2009
J.K. WallAnother year of rapid change at Eli Lilly and Co. did little to move the company out from under the cloud cast by its best-selling
drug, Zyprexa.
MoreTo keep sales force busy, Lilly takes on new drug
December 24, 2009
J.K. WallEli Lilly and Co. has bought the rights to co-market a new cholesterol-fighting drug in the U.S., giving it a third heart
drug for sales personnel
to push.
MoreLilly pays $90 million for autoimmune drug
December 21, 2009
IBJ StaffBy acquiring an experimental medicine for rheumatoid arthritis, the Indianapolis-based drugmaker is increasing its focus on
autoimmune
diseases.
MoreSenate rejects drug-importation proposal
December 16, 2009
IBJ Staff and Associated PressThe U.S. Senate voted down a plan Tuesday to allow Americans to import prescriptions from abroad, handing drug makers
such as Indianapolis-based Eli Lilly and Co. a victory.
MoreLilly wins approval for long-acting Zyprexa
December 14, 2009
J.K. WallOnce-a-month injection of best-selling drug will have patents that could extend until 2018.
MoreEli Lilly's shares slip after it forecasts mixed profits in coming years
December 10, 2009
IBJ Staff and Associated PressThe Indianapolis-based drugmaker predicts strong profits through 2011, but its forecast for 2012 suggests bottom-line results
could fall precipitously.
MoreLilly launching new venture capital fund
December 10, 2009
J.K. WallThe fund would acquire experimental drugs and use Lilly R&D staff to try to prove their effectiveness, perhaps boosting Lilly's
drug pipeline.
MoreAriad asks court to restore patent-suit win against Lilly
December 8, 2009
IBJ StaffA federal appeals court will decide whether Eli Lilly and Co. must pay $65.2 million in damages, plus royalties, over a drug-patent
claim.
MoreBuilder looks to cold storage for steady work in a weak economy
December 5, 2009
Brock BenefielCold storage might become a hot business for a building contractor.
MorePart of Mississippi's Zyprexa case against Lilly dismissed
December 2, 2009
IBJ StaffIndianapolis-based Eli Lilly and Co. has won a bid to dismiss part of a negligence lawsuit brought by Mississippi that alleges
improper marketing of antipsychotic drug Zyprexa for unapproved uses.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Good ole' Obamacare. Thanks liberals and those who didn't bother to vote.
Yes. Blame those who were too lazy to go vote Obama out and those who voted him in again. That's my take on it. I know folks won't get it on the left. OK. Start berating me now!
Serioulsy, people are AGINST this project? Most communities would be salivating over a project like this. You'd rather have an empty eye-sore gas station and shacks posing as apartments? This project is exactly what BR needs. BUILD IT MR MAYOR. And yes, I am a BR resident, and have been for 20 years.
As a St. Vincent employee of over 20 years, I am saddened and disheartened by this announcement. Unfortunately, as the healthcare "industry" continues on this political and corporate path, all that St. Vincent Hospital has stood for spiritually for its employees and this community is being sucked dry. I know it truly has no choice. It is not just Obamacare or just competition or just any single thing. This trend started long before I was even born when the government became involved in healthcare and it became an "industry." I grieve for those who will lose their jobs, one of whom may be me, but I also grieve for this hospital which I have served for over 20 years. May God give us and it the grace to withstand the future of healthcare.
Why do people constantly harp on this issue and act ignorant about what a city population measures? A city's population is the city's population. There is no argument or debate about it. If you want to measure the density of a city--measure it. If you want to measure the size of a metropolitan area, then measure the metropolitan population. City boundaries cover different sized areas--and they always have (though the disparity has probably increased since about 1900 or so when more cities began annexing their surrounding communities). For example, San Francisco only covers 49 square miles while Houston cover nearly 600 square miles. No one argues about the population rankings of either city even though they clearly cover extremely different sized areas. Indianapolis is the 13 largest city by population in the U.S. That is a fact. While the population of a metropolitan area may give you a better sense of how large a community is, as noted, even metro areas can vary widely in the size of geographic area they cover--so that is not a perfect comparison either.